Eric Nuermberger


If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 24 Similar Profiles
Tuberculosis Medicine & Life Sciences
rifapentine Medicine & Life Sciences
Pyrazinamide Medicine & Life Sciences
Rifampin Medicine & Life Sciences
Mycobacterium tuberculosis Medicine & Life Sciences
Linezolid Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

Activity of a long-acting injectable bedaquiline formulation in a paucibacillary mouse model of latent tuberculosis infection

Kaushik, A., Ammerman, N., Tyagi, S., Saini, V., Vervoort, I., Lachau-Durand, S., Nuermberger, E. & Andries, K., Apr 1 2019, In : Antimicrobial agents and chemotherapy. e00007-19.

Research output: Contribution to journalArticle

Open Access
Latent Tuberculosis

Advancing translational science for pulmonary nontuberculous mycobacterial infections: A road map for research

Daniel-Wayman, S., Abate, G., Barber, D. L., Bermudez, L. E., Coler, R. N., Cynamon, M. H., Daley, C. L., Davidson, R. M., Dick, T., Floto, R. A., Henkle, E., Holland, S. M., Jackson, M., Lee, R. E., Nuermberger, E., Olivier, K. N., Ordway, D. J., Prevots, D. R., Sacchettini, J. C., Salfinger, M. & 4 othersSassetti, C. M., Sizemore, C. F., Winthrop, K. L. & Zelazny, A. M., Apr 15 2019, In : American journal of respiratory and critical care medicine. 199, 8, p. 947-951 5 p.

Research output: Contribution to journalReview article


Contribution of pretomanid to novel regimens containing bedaquiline with either linezolid or moxifloxacin and pyrazinamide in murine models of tuberculosis

Xu, J., Li, S. Y., Almeida, D. V., Tasneen, R., Barnes-Boyle, K., Converse, P. J., Upton, A. M., Mdluli, K., Fotouhi, N. & Nuermberger, E., May 1 2019, In : Antimicrobial agents and chemotherapy. 63, 5, e00021-19.

Research output: Contribution to journalArticle

Open Access
Nude Mice

High-dose rifamycins enable shorter oral treatment in a murine model of mycobacterium ulcerans disease

Omansen, T. F., Almeida, D., Converse, P. J., Li, S. Y., Lee, J., Stienstra, Y., van der Werf, T., Grosset, J. H. & Nuermberger, E., Feb 1 2019, In : Antimicrobial Agents and Chemotherapy. 63, 2, e01478-18.

Research output: Contribution to journalArticle

Mycobacterium ulcerans
Buruli Ulcer
Pharmaceutical Preparations
Salvage Therapy
Mycobacterium Infections